Literature DB >> 22188182

Fragile X syndrome: the FMR1 CGG repeat distribution among world populations.

Emmanuel Peprah1.   

Abstract

Fragile X syndrome (FXS) is characterized by moderate to severe intellectual disability, which is accompanied by macroorchidism and distinct facial morphology. FXS is caused by the expansion of the CGG trinucleotide repeat in the 5' untranslated region of the fragile X mental retardation 1 (FMR1) gene. The syndrome has been studied in ethnically diverse populations around the world and has been extensively characterized in several populations. Similar to other trinucleotide expansion disorders, the gene-specific instability of FMR1 is not accompanied by genomic instability. Currently we do not have a comprehensive understanding of the molecular underpinnings of gene-specific instability associated with tandem repeats. Molecular evidence from in vitro experiments and animal models supports several pathways for gene-specific trinucleotide repeat expansion. However, whether the mechanisms reported from other systems contribute to trinucleotide repeat expansion in humans is not clear. To understand how repeat instability in humans could occur, the CGG repeat expansion is explored through molecular analysis and population studies which characterized CGG repeat alleles of FMR1. Finally, the review discusses the relevance of these studies in understanding the mechanism of trinucleotide repeat expansion in FXS. Annals of Human Genetics
© 2011 Blackwell Publishing Ltd/University College London Published 2011. This article is a US Government work and is in the public domain in the USA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22188182      PMCID: PMC3288311          DOI: 10.1111/j.1469-1809.2011.00694.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  163 in total

1.  Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation.

Authors:  David Hessl; Flora Tassone; Danuta Z Loesch; Elizabeth Berry-Kravis; Maureen A Leehey; Louise W Gane; Ingrid Barbato; Cathlin Rice; Emma Gould; Deborah A Hall; James Grigsby; Jacob A Wegelin; Susan Harris; Foster Lewin; Dahlia Weinberg; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-11-05       Impact factor: 3.568

2.  FRAXA screening in Brazilian institutionalized individuals with nonspecific severe mental retardation.

Authors:  M V Mulatinho; J C Llerena; M M Pimentel
Journal:  Genet Test       Date:  2000

3.  [Fragile X syndrome. Clinical analysis of 300 Chilean patients with unspecific mental retardation].

Authors:  M Aspillaga; L Jara; I Avendaño; M López
Journal:  Rev Med Chil       Date:  1998-12       Impact factor: 0.553

4.  Association of FMR1 repeat size with ovarian dysfunction.

Authors:  A K Sullivan; M Marcus; M P Epstein; E G Allen; A E Anido; J J Paquin; M Yadav-Shah; S L Sherman
Journal:  Hum Reprod       Date:  2004-12-17       Impact factor: 6.918

5.  Molecular characterization of the fragile-X syndrome in the Mexican population.

Authors:  M Y Díaz-Gallardo; P Barros-Núñez; C A Díaz; A Hernández; I Gómez-Espinel; C A Leal; R Fragoso; L Figuera; D García-Cruz; M L Ramírez-Dueñas
Journal:  Arch Med Res       Date:  1995       Impact factor: 2.235

6.  Population studies of the fragile X: a molecular approach.

Authors:  P A Jacobs; H Bullman; J Macpherson; S Youings; V Rooney; A Watson; N R Dennis
Journal:  J Med Genet       Date:  1993-06       Impact factor: 6.318

7.  Fragile X carrier screening and FMR1 allele distribution in the Japanese population.

Authors:  Susumu Otsuka; Yumiko Sakamoto; Haruhiko Siomi; Mituo Itakura; Kenji Yamamoto; Hideo Matumoto; Tsukasa Sasaki; Nobumasa Kato; Eiji Nanba
Journal:  Brain Dev       Date:  2009-02-10       Impact factor: 1.961

8.  Paternal transmission of fragile X syndrome.

Authors:  Susan Zeesman; Lonnie Zwaigenbaum; Donald T Whelan; Randi J Hagerman; Flora Tassone; Sherryl A M Taylor
Journal:  Am J Med Genet A       Date:  2004-08-30       Impact factor: 2.802

9.  Reduced Hippocampal Activation During Recall is Associated with Elevated FMR1 mRNA and Psychiatric Symptoms in Men with the Fragile X Premutation.

Authors:  Kami Koldewyn; David Hessl; John Adams; Flora Tassone; Paul J Hagerman; Randi J Hagerman; Susan M Rivera
Journal:  Brain Imaging Behav       Date:  2008-01-18       Impact factor: 3.978

Review 10.  Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.

Authors:  Randi J Hagerman; Deborah A Hall; Sarah Coffey; Maureen Leehey; James Bourgeois; John Gould; Lin Zhang; Andreea Seritan; Elizabeth Berry-Kravis; John Olichney; Joshua W Miller; Amy L Fong; Randall Carpenter; Cathy Bodine; Louise W Gane; Edgar Rainin; Hillary Hagerman; Paul J Hagerman
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more
  34 in total

1.  The FMR1 CGG repeat test is not a candidate prescreening tool for identifying women with a high probability of being carriers of BRCA mutations.

Authors:  Maria Teresa Ricci; Loredana Pennese; Viviana Gismondi; Chiara Perfumo; Marina Grasso; Elena Gennaro; Paolo Bruzzi; Liliana Varesco
Journal:  Eur J Hum Genet       Date:  2013-09-25       Impact factor: 4.246

2.  AMH in women with diminished ovarian reserve: potential differences by FMR1 CGG repeat level.

Authors:  Lisa M Pastore; Timothy L McMurry; Christopher D Williams; Valerie L Baker; Steven L Young
Journal:  J Assist Reprod Genet       Date:  2014-06-18       Impact factor: 3.412

3.  A comparison of family financial and employment impacts of fragile X syndrome, autism spectrum disorders, and intellectual disability.

Authors:  Lijing Ouyang; Scott D Grosse; Catharine Riley; Julie Bolen; Ellen Bishop; Melissa Raspa; Donald B Bailey
Journal:  Res Dev Disabil       Date:  2014-04-20

4.  Vagal Tone as a Putative Mechanism for Pragmatic Competence: An Investigation of Carriers of the FMR1 Premutation.

Authors:  Jessica Klusek; Amanda J Fairchild; Jane E Roberts
Journal:  J Autism Dev Disord       Date:  2019-01

Review 5.  DNA methylation in mammals.

Authors:  En Li; Yi Zhang
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-05-01       Impact factor: 10.005

6.  The Fragile X proteins Fmrp and Fxr2p cooperate to regulate glucose metabolism in mice.

Authors:  Jeannette G Lumaban; David L Nelson
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

7.  Distribution of AGG interruption patterns within nine world populations.

Authors:  Carolyn M Yrigollen; Stefan Sweha; Blythe Durbin-Johnson; Lili Zhou; Elizabeth Berry-Kravis; Isabel Fernandez-Carvajal; Sultana Mh Faradz; Khaled Amiri; Huda Shaheen; Roberta Polli; Luis Murillo-Bonilla; Gabriel de Jesus Silva Arevalo; Patricia Cogram; Alessandra Murgia; Flora Tassone
Journal:  Intractable Rare Dis Res       Date:  2014-11

8.  Alterations in the Sp1 binding and Fmr-1 gene expression in the cortex of the brain during maturation and aging of mouse.

Authors:  Pankaj Gaur; S Prasad
Journal:  Mol Biol Rep       Date:  2014-07-12       Impact factor: 2.316

Review 9.  From FMRP function to potential therapies for fragile X syndrome.

Authors:  Ferzin Sethna; Changjong Moon; Hongbing Wang
Journal:  Neurochem Res       Date:  2013-12-18       Impact factor: 3.996

10.  Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve.

Authors:  Lisa M Pastore; Steven L Young; Valerie L Baker; Logan B Karns; Christopher D Williams; Lawrence M Silverman
Journal:  Reprod Sci       Date:  2012-05-10       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.